Board Change • Jul 22
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • May 23
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 4 experienced directors. No highly experienced directors. 1 independent director (3 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • May 16
Innlanz Limited (ASX:INL) announces an Equity Buyback for 63,263,608 shares, representing 20.2% for AUD 0.82 million. Innlanz Limited (ASX:INL) announces a share repurchase program. Under the program, the company will repurchase up to 63,263,608 shares, representing 20.2% of its issued share capital. The shares will be repurchased at a price of AUD 0.013 per share. The purpose of the program is to provide all the shareholders the opportunity to potentially realize some or all of their investment in the company before the delisting. The repurchased shares will be cancelled. The offer will be funded from by an interest fee debt facility with a principal amount of up to AUD 0.82 million from Pacific Merchants Group Pty Ltd. The offer is subject to shareholder approval to be obtained at the General Meeting to be held on June 14, 2024. The company has fixed June 20, 2024, as the record date for the offer. The offer will expire on July 12, 2024. As of May 15, 2024, the company had 313,263,608 shares in issue. Announcement • Feb 28
Innlanz Limited Announces Resignation of Jhon Shen as Executive Director Innlanz Limited announced that Mr. Jhon Shen has resigned as Executive Director of the company, due to personal reasons, effective immediately. Mr. Shen remains the major shareholder and has indicated that he will continue to act in the best interests of the Company. Board Change • Feb 08
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jan 23
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Dec 19
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Nov 10
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Oct 19
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Oct 02
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Sep 22
Innlanz Limited, Annual General Meeting, Nov 16, 2023 Innlanz Limited, Annual General Meeting, Nov 16, 2023, at 11:01 AUS Eastern Standard Time. Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.001 loss per share (vs AU$0.003 loss in FY 2022) Full year 2023 results: AU$0.001 loss per share (improved from AU$0.003 loss in FY 2022). Revenue: AU$2.64m (up 66% from FY 2022). Net loss: AU$283.1k (loss narrowed 68% from FY 2022). Over the last 3 years on average, earnings per share has increased by 87% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. New Risk • Aug 31
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Shares are highly illiquid. Earnings have declined by 12% per year over the past 5 years. Market cap is less than US$10m (AU$8.46m market cap, or US$5.48m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Revenue is less than US$5m (AU$2.3m revenue, or US$1.5m). Board Change • Aug 25
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jul 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • May 10
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Apr 11
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Mar 03
First half 2023 earnings released: EPS: AU$0 (vs AU$0.002 loss in 1H 2022) First half 2023 results: EPS: AU$0 (improved from AU$0.002 loss in 1H 2022). Revenue: AU$1.29m (up 119% from 1H 2022). Net loss: AU$15.0k (loss narrowed 97% from 1H 2022). Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 39% per year, which means it is significantly lagging earnings. Board Change • Feb 09
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Jan 05
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Dec 08
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Nov 16
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. 1 independent director (4 non-independent directors). Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Oct 10
Innlanz Limited, Annual General Meeting, Nov 30, 2022 Innlanz Limited, Annual General Meeting, Nov 30, 2022, at 11:01 AUS Eastern Standard Time. Board Change • Sep 05
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Jul 30
Innlanz Limited Announces the Resignation of Tracey Cray as Director, Effective 31 July 2022 Innlanz Limited announced that Ms. Tracey Cray will step down from her role of Non-Executive Director and also from other Innlanz sub-committees effective 31 July 2022. The decision to step down follows Ms. Cray's appointment to a full-time executive role within another company. Board Change • Jun 22
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • May 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 01
Full year 2021 earnings released: AU$0.02 loss per share (vs AU$0.016 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: AU$1.16m (down 95% from FY 2020). Net loss: AU$6.43m (loss widened 26% from FY 2020). Board Change • Sep 01
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Board Change • Aug 16
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 5 non-independent directors. Independent Non-Executive Chairman Peter French was the last independent director to join the board, commencing their role in 2018. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 30
Mediland Pharm Limited (ASX:MPH) completed the acquisition of Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. Mediland Pharm Limited (ASX:MPH) agreed to acquire Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. for AUD 2.5 million on November 4, 2020. Under the terms of consideration, purchase price of the business is AUD 2.5 million excluding the external debt the Hotel currently has of AUD 2 million. The proposed transaction is to be settled in cash with $100,000 payable upon completion and the balance payable monthly in the 24 months from the date of the SPA. Source of funds for the transaction will be from Mediland Pharm Limitedand its controlled entities which will include operational cash flows from Heartland. The deal is subject to certain conditions precedent, and subject to shareholder approval in a general meeting, which will be scheduled as soon as possible, subject to complying with relevant ASIC and ASX requirements, the Directors of Mediland have recommended that the Mediland Pharm Limited proceed to acquire 100% of shares in the Heartland Ambassador Hamilton Hotel. Completion of the transaction is anticipated by mid-January 2021. Colliers International have conducted an independent valuation of the Hotel. The Board of the Company established an Independent Committee (Due Diligence Committee) to consider the Company’s proposed transaction in relation to the acquisition of the Hamilton Hotel. The DDC comprises of the Independent Non-executive Director Tracey-Lee Cray (Chair of the DDC), Independent Board Chair Dr Peter French, Independent Non-executive Director Theo Renard, and Independent Non-executive Director Leo Cui. Ixora Investments reported total assets of AUD 5.4 million, loss of AUD 0.03 million and total common equity of AUD 2.5 million for the year ending December 31, 2020. Mediland is to hold a meeting of shareholders where it will seek approval from non-associated shareholders for the Proposed Transaction. As of April 29, 2021, an Extraordinary General Meeting will be held at which shareholder approval will be sought for the approval of the acquisition of 100% of the shares in Ixora Investments Pty Limited. RSM Corporate Australia Pty Ltd, Financial Advisory Arm acted as a fairness opinion advisor to Mediland.
Mediland Pharm Limited (ASX:MPH) completed the acquisition of Heartland Ambassador Hamilton Hotel from Premier Hospitality Management Pty Ltd. on April 29, 2021. Announcement • Nov 05
Mediland Pharm Limited (ASX:MPH) agreed to acquire Heartland Ambassador Hamilton Hotel for AUD 2.5 million. Mediland Pharm Limited (ASX:MPH) agreed to acquire Heartland Ambassador Hamilton Hotel for AUD 2.5 million on November 4, 2020. Under the terms of consideration, purchase price of the business is AUD 2.5 million excluding the external debt the Hotel currently has of AUD 2 million. The deal is subject to certain conditions precedent, and subject to shareholder approval in a general meeting, which will be scheduled as soon as possible, subject to complying with relevant ASIC and ASX requirements, the Directors of Mediland have recommended that the Mediland Pharm Limited proceed to acquire 100% of shares in the Heartland Ambassador Hamilton Hotel. Completion of the transaction is anticipated by mid-January 2021. Colliers International have conducted an independent valuation of the Hotel. Reported Earnings • Oct 26
Full year earnings released - AU$0.016 loss per share Over the last 12 months the company has reported total losses of AU$5.11m, with losses widening by AU$5.09m from the prior year. Total revenue was AU$23.3m over the last 12 months, down 24% from the prior year. Announcement • Jul 31
Mediland Pharm Limited (ASX:MPH) completed the acquisition of Ian’s Health Lounge business. Mediland Pharm Limited (ASX:MPH) entered into a conditional business sale agreement to acquire Ian’s Health Lounge business for AUD 0.5 million on April 2, 2019. The purchase price is AUD 0.5 million adjusted by any debt owed by Ian’s Health Lounge to the current Director. As part of the agreement, the founders of the business will remain on board. The transaction is subject to the usual and ordinary conditions, including the Board of Mediland Pharm Limited being satisfied with the due diligence on the business. As of July 22, 2019, due diligence for the transaction has been completed. The transaction is expected to be completed by the end of June 2019. As of July 19, 2019, stage one of transaction has been completed. The transaction will accelerate Mediland’s growth.
Mediland Pharm Limited (ASX:MPH) completed the acquisition of Ian’s Health Lounge business on October 1, 2019. 
